Growth Metrics

Dexcom (DXCM) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.19%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 64.73%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.89%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 29.56%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 0.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.12%
Dec 31, 2025 42.80%
Sep 30, 2025 41.02%
Jun 30, 2025 52.30%
Mar 31, 2025 2.70%
Dec 31, 2024 212.86%
Sep 30, 2024 15.53%
Jun 30, 2024 22.32%
Mar 31, 2024 37.35%
Dec 31, 2023 -14.59%
Sep 30, 2023 18.68%
Jun 30, 2023 35.78%
Mar 31, 2023 34.67%
Dec 31, 2022 -0.32%
Sep 30, 2022 30.25%
Jun 30, 2022 89.89%
Mar 31, 2022 77.76%
Dec 31, 2021 69.10%
Sep 30, 2021 23.28%
Jun 30, 2021 37.44%
Mar 31, 2021 63.05%
Dec 31, 2020 257.67%
Sep 30, 2020 236.49%
Jun 30, 2020 151.80%
Mar 31, 2020 35.31%
Dec 31, 2019 144.00%
Sep 30, 2019 64.31%
Jun 30, 2019 19.60%
Mar 31, 2019 -11.90%
Dec 31, 2018 -395.70%
Sep 30, 2018 45.75%
Jun 30, 2018 116.60%
Mar 31, 2018 -23.33%
Dec 31, 2017 -105.78%
Sep 30, 2017 27.28%
Jun 30, 2017 35.42%
Mar 31, 2017 -49.42%
Dec 31, 2016 -41.72%
Sep 30, 2016 -46.33%
Jun 30, 2016 -25.99%
Mar 31, 2016 -20.04%
Dec 31, 2015 29.59%
Sep 30, 2015 -34.93%
Jun 30, 2015 36.86%
Mar 31, 2015 2.92%
Dec 31, 2014 28.36%
Sep 30, 2014 26.84%
Jun 30, 2014 6.61%
Mar 31, 2014 -1.80%
Dec 31, 2013 35.81%
Sep 30, 2013 22.89%
Jun 30, 2013 4.07%